TSXV - Free Realtime Quote • CAD
NexgenRx Inc. (NXG.V)
As of April 15 at 10:56 AM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Ronald C. Loucks B.B.A. | Founder, CEO, President & Director | 286.66k | -- | 1950 |
| Mr. Kelly Elher C.A., CPA, CA, CPA | Chief Financial Officer | 120k | -- | -- |
| Mr. Andrew Munroe | Senior Vice President of Pharma & Payor Partners | 177.98k | -- | -- |
| Mr. Jason Robinson | Senior Vice President of Administration | -- | -- | -- |
| Ms. Doreen Harvey | Lead Human Resources | -- | -- | -- |
| Mr. Paul Anthony Bolger LL.B., M.B.A. | Company Secretary | -- | -- | -- |
| Mr. Avik Debroy | Financial Controller | -- | -- | -- |
NexgenRx Inc.
- Sector:
- Healthcare
- Industry: Healthcare Plans
Description
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.
Corporate Governance
NexgenRx Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
- Jan 04, 2024Dividend Date
- Dec 28, 2023Ex-Dividend Date
Upcoming Events
May 06, 2024 - May 10, 2024
NexgenRx Inc. Earnings Call